Development of patient-friendly preparations: Preparation of a new allopurinol mouthwash containing polyethylene(oxide) and carrageenanHANAWA, Takehisa; MASUDA, Nami; MOHRI, Kiminori et al.Drug development and industrial pharmacy. 2004, Vol 30, Num 2, pp 151-161, issn 0363-9045, 11 p.Article

Detection of HLA-B^*58:01, the susceptible allele for allopurinol-induced hypersensitivity, by loop-mediated isothermal amplificationKWOK, J; KWONG, K. M.British journal of dermatology (1951). 2013, Vol 168, Num 3, pp 526-532, issn 0007-0963, 7 p.Article

Intravenous Allopurinol in the Prevention and Treatment of Tumor Lysis SyndromeDUTCHER, Janice P.Seminars in oncology. 2001, Vol 28, Num 2, issn 0093-7754, 23 p., SUP5Serial Issue

Allopurinol hypersensitivity syndrome: hypersensitivity to oxypurinol but not allopurinolHAMANAKA, H; MIZUTANI, H; NOUCHI, N et al.Clinical and experimental dermatology (Print). 1998, Vol 23, Num 1, pp 32-34, issn 0307-6938Article

A Case of Gingival Ulcer Thought to Be Caused by AllopurinolSATO, Chu; NOMURA, Joji; MATSUMURA, Yoshihiko et al.Journal of oral and maxillofacial surgery. 2009, Vol 67, Num 11, pp 2510-2513, issn 0278-2391, 4 p.Article

Allopurinol et aplasie médullaire = Allopurinol and bone marrow aplasiaLa Revue Prescrire. 2002, Vol 22, Num 232, issn 0247-7750, p. 669Article

Starting Dose Is a Risk Factor for Allopurinol Hypersensitivity Syndrome: A Proposed Safe Starting Dose of AllopurinolSTAMP, Lisa K; TAYLOR, William J; JONES, Peter B et al.Arthritis and rheumatism. 2012, Vol 64, Num 8, pp 2529-2536, issn 0004-3591, 8 p.Article

Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans: ErratumKANG, H. R; JEE, Y. K; KIM, Y. S et al.Pharmacogenetics and genomics (Print). 2012, Vol 22, Num 8, issn 1744-6872, p. 652Article

Allopurinol in der Behandlung de kutanen Sarkoidose = Allopurinol in the treatment of cutaneous sarcoidosisPFAU, A; STOLZ, W; KARRER, S et al.Hautarzt. 1998, Vol 49, Num 3, pp 216-218, issn 0017-8470Article

Baboon-Syndrom auf Allopurinol = Baboon syndrome caused to allopurinolMONTAG, G; WEBER, L; GALL, H et al.Aktuelle Dermatologie. 1996, Vol 22, Num 11, pp 311-313, issn 0340-2541Article

Allopurinol is effective to modify the evolution of Trypanosoma cruzi infection in miceGOBBI, Paola; LO PRESTI, Maria S; FERNANDEZ, Alicia R et al.Parasitology research (1987). 2007, Vol 101, Num 5, pp 1459-1462, issn 0932-0113, 4 p.Article

Tumour lysis syndrome: new therapeutic strategies and classificationCAIRO, Mitchell S; BISHOP, Michael.British journal of haematology. 2004, Vol 127, Num 1, pp 3-11, issn 0007-1048, 9 p.Article

Pharmakogenetik : Neue kutane Arzneimittelnebenwirkunger = Pharmacogenetics : New cutaneous side effects of drugsMERK, H. F.Der Hautarzt. 2010, Vol 61, Num 8, pp 650-653, issn 0017-8470, 4 p.Article

Canine leishmaniosis: in vitro efficacy of miltefosine and marbofloxacin alone or in combination with allopurinol against clinical strains of Leishmania infantumFARCA, Anna Maria; MINISCALCO, B; BADINO, P et al.Parasitology research (1987). 2012, Vol 110, Num 6, pp 2509-2513, issn 0932-0113, 5 p.Article

Allopurinol-Induced DRESS Syndrome in an Adolescent PatientDEWAN, Ashvin K; QUINONEZ, Ricardo A.Pediatric dermatology. 2010, Vol 27, Num 3, pp 270-273, issn 0736-8046, 4 p.Article

Association of clomipramine and allopurinol for the treatment of the experimental infection with Trypanosoma cruziGOBBI, Paola; BAEZ, Alejandra; LO PRESTI, Maria Silvina et al.Parasitology research (1987). 2010, Vol 107, Num 5, pp 1279-1283, issn 0932-0113, 5 p.Article

Allopurinol enhanced thiopurine treatment for inflammatory bowel disease: safety considerations and guidelines for useMIN, M. X; WEINBERG, D. I; McCABET, R. P et al.Journal of clinical pharmacy and therapeutics (Print). 2014, Vol 39, Num 2, pp 107-111, issn 0269-4727, 5 p.Article

Utilization patterns of Antihyperuricemic Agents Following Safety Announcement on Allopurinol and Benzbromarone by Taiwan Food and Drug AdministrationCHENG, Ching-Lan; CHAO, Pi-Huei; HSU, Jason Chih-Sheng et al.Pharmacoepidemiology and drug safety. 2014, Vol 23, Num 3, pp 309-313, issn 1053-8569, 5 p.Article

A Review Investigating the Effect of Allopurinol on the Progression of Kidney Disease in Hyperuricemic Patients With Chronic Kidney DiseaseKABUL, Samaneh; SHEPLER, Brian.Clinical therapeutics. 2012, Vol 34, Num 12, pp 2293-2296, issn 0149-2918, 4 p.Article

Secondary biliary cirrhosis in the rat is prevented by decreasing NF-κB nuclear translocation and TGF-β expression using allopurinol, an inhibitor of xanthine oxidaseALDABA-MURUATO, Liseth R; MORENO, Mario G; HERNANDEZ-MERCADO, Elisa et al.Canadian journal of physiology and pharmacology. 2012, Vol 90, Num 11, pp 1469-1478, issn 0008-4212, 10 p.Article

Toxidermies à l'allopurinolGRENIER, Antoine.La Revue du praticien. Médecine générale. 2012, Num 891, issn 0989-2737, p. 829Article

UN CAS DE LEISHMANIOSE FÉLINE DISSÉMINÉE DANS LE SUD DE LA FRANCE = A CASE OF FELINE LEISHMANIASIS IN THE SOUTH OF FRANCEPOCHOLLE, E; REYES-GOMEZ, E; GIACOMO, A et al.Parasite (Paris). 2012, Vol 19, Num 1, pp 77-80, issn 1252-607X, 4 p.Article

HLA-B58 can help the clinical decision on starting allopurinol in patients with chronic renal insufficiencyJUN, Jae-Woo; SONG, Woo-Jung; KANG, Hye-Ryun et al.Nephrology, dialysis, transplantation (Print). 2011, Vol 26, Num 11, pp 3567-3572, issn 0931-0509, 6 p.Article

N-(2-mercaptopropionyl)-glycine but not Allopurinol prevented cigarette smoke-induced alveolar enlargement in mousePEREIRA PIRES, Karla Maria; SILVA BEZERRA, Frank; NASCIMENTO MACHADO, Mariana et al.Respiratory physiology & neurobiology. 2011, Vol 175, Num 3, pp 322-330, issn 1569-9048, 9 p.Article

Safety and Efficacy of Febuxostat Treatment in Subjects with Gout and Severe Allopurinol Adverse ReactionsCHOHAN, Saima.Journal of rheumatology. 2011, Vol 38, Num 9, pp 1957-1959, issn 0315-162X, 3 p.Article